O
Oliver Distler
Researcher at University of Zurich
Publications - 687
Citations - 37125
Oliver Distler is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Fibrosis. The author has an hindex of 85, co-authored 591 publications receiving 29269 citations. Previous affiliations of Oliver Distler include University of Genoa & University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Bashar Kahaleh,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,Robert W. Simms,John Varga,Janet E. Pope +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank H J van den Hoogen,Dinesh Khanna,Jaap Fransen,Sindhu R Johnson,Murray Baron,Alan Tyndall,Marco Matucci-Cerinic,Raymond P. Naden,Thomas A. Medsger,Patricia Carreira,Gabriela Riemekasten,Philip J. Clements,Christopher P. Denton,Oliver Distler,Yannick Allanore,Daniel E. Furst,Armando Gabrielli,Maureen D. Mayes,Jacob M van Laar,James R. Seibold,László Czirják,Virginia D. Steen,Murat Inanc,Otylia Kowal-Bielecka,Ulf Müller-Ladner,Gabriele Valentini,Douglas J. Veale,Madelon C. Vonk,Ulrich A Walker,Lorinda Chung,David H. Collier,David H. Collier,Mary Ellen Csuka,Barri J. Fessler,Serena Guiducci,Ariane L. Herrick,Ariane L. Herrick,Vivien Hsu,Sergio A. Jimenez,Bashar Kahaleh,Peter A. Merkel,Peter A. Merkel,Stanislav Sierakowski,Richard M. Silver,Robert W. Simms,John Varga,Janet E. Pope +46 more
TL;DR: The ACR/EULAR classification criteria for SSc performed better than the 1980 ACR criteria and should allow for more patients to be classified correctly as having the disease.
Journal ArticleDOI
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
A Tyndall,Bettina Bannert,Madelon C. Vonk,Paolo Airò,Franco Cozzi,Patricia Carreira,Dominique Farge Bancel,Yannick Allanore,Ulf Müller-Ladner,Oliver Distler,Florenzo Iannone,Raffaele Pellerito,Margarita Pileckyte,I. Miniati,L. Ananieva,Alexandra Balbir Gurman,Nemanja Damjanov,Adelheid Mueller,Gabriele Valentini,Gabriela Riemekasten,Mohammed Tikly,Laura K. Hummers,Maria João Henriques,Paola Caramaschi,Agneta Scheja,Blaz Rozman,Evelien Ton,Gábor Kumánovics,Bernard Coleiro,Eva Feierl,Gabriella Szücs,Carlos Alberto Von Mühlen,Valeria Riccieri,Srdan Novak,Carlo Chizzolini,Anna Kotulska,Christopher P. Denton,Paulo C. Coelho,Ina Kötter,Ismail Simsek,Paloma García de la Peña Lefebvre,Eric Hachulla,James R. Seibold,Simona Rednic,Jiri Stork,Jadranka Morović-Vergles,Ulrich A. Walker +46 more
TL;DR: Disease-related causes, in particular pulmonary fibrosis, PAH and cardiac causes, accounted for the majority of deaths in SSc.
Journal ArticleDOI
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
TL;DR: The adverse-event profile of nintedanib observed in this trial was similar to that observed in patients with idiopathic pulmonary fibrosis; gastrointestinal adverse events, including diarrhea, were more common with nintinganib than with placebo.
Journal ArticleDOI
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka,Jaap Fransen,Jérôme Avouac,Mike O Becker,Mike O Becker,Agnieszka Kulak,Yannick Allanore,Oliver Distler,Philip J. Clements,Maurizio Cutolo,László Czirják,Nemanja Damjanov,Francesco Del Galdo,Christopher P. Denton,Jörg H W Distler,Ivan Foeldvari,Kim Figelstone,Marc Frerix,Daniel E. Furst,Serena Guiducci,Nicolas Hunzelmann,Dinesh Khanna,Marco Matucci-Cerinic,Ariane L. Herrick,Frank J. A. van den Hoogen,Jacob M van Laar,Gabriela Riemekasten,Richard M. Silver,Vanessa Smith,Vanessa Smith,Alberto Sulli,Ingo H. Tarner,Alan Tyndall,Joep Welling,Frederic Wigley,Gabriele Valentini,Ulrich A Walker,Francesco Zulian,Ulf Müller-Ladner +38 more
TL;DR: In this article, the European League against Rheumatism (EULAR) developed a set of recommendations for the treatment of systemic sclerosis (SSc) with attention to new therapeutic questions.